HRT Financial’s Innovative Eyewear LUCY Stock Holding History

HRT Financial’s Portfolio LUCY Stock Details LUCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-619	Closed	-$7K	–	2752
2023 Q3	$7K	Sell	619 -198	-24%	-$2.89K	﹤0.01%	2153
2023 Q2	$14K	Buy	+817	New	+$35.4K	﹤0.01%	2135

Other funds holding LUCY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's LUCY Position: Q4 2023 in Review

HRT Financial sold out of Innovative Eyewear (LUCY) in Q4 2023, closing a stake of 619 shares — an estimated $7K sold.

HRT Financial first reported a position in LUCY in Q2 2023 and held it in 2 quarters. The position peaked at $14K in Q2 2023. 8 funds tracked by Wall St. Rank hold LUCY as of Q4 2023.

HRT Financial reported no remaining Innovative Eyewear position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 619 Innovative Eyewear shares in Q4 2023, an estimated $7K.
HRT Financial first reported a position in Innovative Eyewear in Q2 2023 and held it in 2 quarters.
HRT Financial's Innovative Eyewear position peaked at $14K in Q2 2023.
8 funds tracked by Wall St. Rank held Innovative Eyewear as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.